Helimeds

Semaglutide Side Effects: What’s Common, What’s Not, and When to Call Your Provider

Weight Loss4 min read

Medically reviewed by: Dr. Elena Cho, MD

Written by: Dr. Elena Cho, MD

Fact Checked

Helimeds’ Fact-Checking Standards. Every piece of content at Helimeds adheres to the highest editorial standards for language, style, and medical accuracy. To learn what we do to deliver the best health insights to you, check out our content review principles.

Most people who start compounded semaglutide feel some side effects in the first few weeks — and most of those fade. Knowing which ones are expected, which ones respond to simple adjustments, and which ones warrant a message to your provider makes the first month far less unsettling.

Semaglutide is a GLP-1 receptor agonist: it slows gastric emptying, reduces appetite signaling, and improves insulin response. Nearly every common side effect traces back to that first mechanism — food simply stays in your stomach longer than you're used to. Your Helimeds provider starts you at a low dose specifically to give your body time to adapt.

What to Expect, Week by Week

The first four weeks are typically the most noticeable, because that's when your dose is lowest but your body is least adapted. Appetite changes usually arrive

within days; digestive effects build over the first two weeks and then taper.

Titration — the scheduled step up in dose — can briefly reintroduce symptoms you'd already moved past. This is expected and not a sign the medication isn't working.

Patient at kitchen table with water and healthy snack
Smaller, slower meals and steady hydration are the two adjustments patients report helping most in weeks 1–4.

Common Side Effects

In clinical trials, the following occurred in more than 5% of participants taking semaglutide for weight management. Most were mild to moderate and resolved without stopping treatment:

  • Nausea — the most frequently reported effect, usually strongest in the 24–48 hours after a dose.
  • Constipation or diarrhea — often alternating, and responsive to fiber and fluid intake.
  • Fatigue — commonly tied to eating less rather than the medication itself.
  • Injection-site tenderness — mild, short-lived, and reduced by rotating sites.
  • Reflux or burping — a direct consequence of slower gastric emptying.

KEY TAKEAWAY

Nausea that eases with smaller meals is expected. Nausea that stops you from keeping fluids down is not — message your provider the same day.

What Usually Helps

  • Eat smaller portions, more slowly, and stop at comfortably full rather than finishing the plate.
  • Prioritize protein and fluids; keep high-fat and very rich meals light on dose days.
  • Take your dose on the same day each week so symptom timing becomes predictable.
  • Rotate injection sites between abdomen, thigh, and upper arm.
  • Log symptoms for your provider — patterns matter more than single bad days.

Medical disclaimer. This article is general health information, not medical advice, and does not replace a consultation with a licensed provider. Compounded medications are not FDA-approved products; they are prepared by a licensed 503A pharmacy to your provider’s prescription. Individual results and side effects vary. Talk to your provider before starting, stopping, or changing any medication.

Less Common and Serious Effects

Serious effects are uncommon but documented, and they require prompt attention rather than watchful waiting.
Contact a provider — or emergency care where indicated — if you experience:

  1. Severe, persistent abdominal pain, particularly radiating to the back (possible pancreatitis).
  2. Vomiting that prevents you from keeping fluids down for more than a few hours.
  3. Right-upper abdominal pain with nausea or jaundice (possible gallbladder involvement).
  4. Vision changes, especially if you have diabetic retinopathy.
  5. Signs of an allergic reaction — swelling, rash, or difficulty breathing (emergency care).

SILDENAFIL

Ready when the moment is

From $1.88/pill

Sildenafil

Safety note. Semaglutide is not appropriate during pregnancy or while breastfeeding, and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Disclose your full medical and medication history during your assessment.

How Semaglutide Compares

Side-effect profiles differ modestly across GLP-1 and dual-agonist options. The table below summarizes commonly reported rates for weight-management dosing.

  1. Severe, persistent abdominal pain, particularly radiating to the back (possible pancreatitis).
  2. Vomiting that prevents you from keeping fluids down for more than a few hours.
  3. Right-upper abdominal pain with nausea or jaundice (possible gallbladder involvement).
  4. Vision changes, especially if you have diabetic retinopathy.
  5. Signs of an allergic reaction — swelling, rash, or difficulty breathing (emergency care).
MedicationNauseaGI Effects OverallTypical Titration
Semaglutide~44%Common, mostly mild4–5 steps over 16–20 weeks
Tirzepatide~29%Common, mostly mild4–5 steps over 20 weeks
Liraglutide~39%Common, mostly mild5 weekly steps
Reported incidence in weight-management trials. Rates vary by dose, titration schedule, and population — use as orientation, not prediction.

What Providers Look For

Adjusting treatment is routine, not a setback. Providers weigh symptom severity against how well the dose is working, and they have several levers before discontinuation becomes the answer — holding at your current dose, extending time between steps, or switching medication.

“ Most patients who stop early do so in the first six weeks, and many of them didn't need to. Slowing the titration schedule resolves the majority of tolerability problems we see. ”

Dr. Elena Cho, MD — Internal Medicine

For a fuller picture of dose progression, see our guide to your first month on compounded semaglutide, or review the reference product’s FDA prescribing information.

A licensed system, built for safety

Most adults are eligible for care. After your questionnaire, a licensed provider reviews your health history and confirms what’s right for you — there’s no strict pass or fail before that.

Start My Quiz

The Bottom Line

Expect some digestive adjustment in the first month; expect it to improve. Report what you're feeling early rather than pushing through, because most tolerability problems have a simple fix. Anything sudden, severe, or persistent is a reason to reach out the same day — not next appointment.

Sources

Helimeds has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid tertiary references. Read our editorial policy.

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989–1002. nejm.org
  2. Semaglutide Injection Prescribing Information. U.S. Food and Drug Administration. 2025. accessdata.fda.gov
  3. Glucagon-Like Peptide-1 Receptor Agonists: Adverse Effects and Monitoring. StatPearls, National Center for Biotechnology Information. 2024. ncbi.nlm.nih.gov
  4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205–216. nejm.org